A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Intention |
---|---|
Submitter | Finland |
Classification
Proposed harmonised classification by the dossier submitter |
|
---|
Intention timeline
Date of intention | 2020-01-09 |
---|---|
Expected date of submission | 2021-01-01 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Feb. 12, 2020
- Regulatory programme: Chemical registered under REACH
March 16, 2020
- Submitter email: CLH_Proposals@tukes.fi
July 21, 2020
- Proposed harmonised classification by the dossier submitter: To be further specified → Skin Sens. 1B, H317
- Status: Intention → Submitted
- Submitted for accordance check: 2020-07-13
Nov. 11, 2020
- CLH report: https://echa.europa.eu/documents/10162/9dad199b-b6df-42b9-bd72-c7f10eaae11c
- Deadline for commenting: 2021-01-22
- Final submission date: 2020-10-09
- Hazard classes open for commenting: Skin sensitisation
- Legal deadline for opinion adoption: 2022-04-10
- Status: Submitted → Consultation
- Start of consultation: 2020-11-09
Feb. 2, 2021
- Status: Consultation → Opinion Development
Feb. 15, 2021
- Comments received: https://echa.europa.eu/documents/10162/ce453eb5-b990-d5b3-c3ac-6ef32bd5f27c
March 31, 2021
- Name: 7,7,9(or 7,9,9)-trimethyl-4,13-dioxo-3,14-dioxa-5,12-diazahexadecane-1,16-diyl bismethacrylate → 11,14-Dioxa-2,9-diazaheptadec-16-enoic acid, 4,4,6,16(or 4,6,6,16)-tetramethyl-10,15-dioxo-, 2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl ester
April 9, 2021
- Name: 11,14-Dioxa-2,9-diazaheptadec-16-enoic acid, 4,4,6,16(or 4,6,6,16)-tetramethyl-10,15-dioxo-, 2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl ester → 7,7,9(or 7,9,9)-trimethyl-4,13-dioxo-3,14-dioxa-5,12-diazahexadecane-1,16-diyl bismethacrylate
Jan. 6, 2022
- Date of opinion: 2021-11-26
- Status: Opinion Development → Opinion Adopted
Feb. 18, 2022
- Background document: https://echa.europa.eu/documents/10162/5937bf2d-72fd-25b9-878a-6a404e329338
- Comments received: https://echa.europa.eu/documents/10162/ce453eb5-b990-d5b3-c3ac-6ef32bd5f27c → https://echa.europa.eu/documents/10162/ff00702e-20c1-075b-2944-71ff249ae710
- RAC opinion: https://echa.europa.eu/documents/10162/118e6fdf-2f58-915b-be2c-e69b77ae57f6
This version
Add the related substance to your watchlist to monitor this regulatory record.